FDA Adverse Event Injury Summary report: N

VERCISE GEVIA

MDR report key: 11508499 · Received March 17, 2021

Report

Report Number
3006630150-2021-01045
Event Type
Injury
Date Received
March 17, 2021
Date of Event
February 23, 2021
Report Date
March 17, 2021
Manufacturer
BOSTON SCIENTIFIC NEUROMODULATION
Product Code
NHL
UDI-DI
08714729984443
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
GA, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

ADDITIONAL SUSPECT MEDICAL DEVICE COMPONENTS INVOLVED IN THE EVENT: PRODUCT FAMILY: DBS-LINEAR LEADS, UPN: (B)(4), MODEL:DB-2202-45, SERIAL: (B)(4), BATCH: 7073119. PRODUCT FAMILY: DBS-LINEAR LEADS, UPN: (B)(4), MODEL:DB-2202-45 , SERIAL: (B)(4), BATCH: 7073127.

Description of Event or Problem · 1

IT WAS REPORTED THAT THE PATIENT WAS IMPLANTED WITH THE DEEP BRAIN STIMULATION (DBS) SYSTEM TO HELP REDUCE PATIENT'S SYMPTOMS OF LEIGH'S SYNDROME. THE DBS SYSTEM DID NOT HELP SO THE PATIENT UNDERWENT AN EXPLANT PROCEDURE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
405595 VERCISE GEVIA STIMULATOR, ELECTRICAL, IMPLANTED, FOR PARKINSONIAN SYMPTOMS NHL BOSTON SCIENTIFIC NEUROMODULATION DB-1200-S 742695 08714729984443

Patients

Seq Age Sex Outcome Treatment
1 12 YR Required Intervention